HCAT Historical PE Ratio image   This HCAT PE ratio history page last updated 8/8/2022
HCAT PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/4/2022
18.27-0.03-0.46NA
Q1 2022
5/10/2022
12.95-0.06-0.43NA
Q4 2021
3/1/2022
26.56-0.19-0.43NA
Q3 2021
11/9/2021
50.51-0.18-0.40NA
Q2 2021
8/5/2021
56.890.00-0.43NA
Q1 2021
5/6/2021
51.47-0.06-0.58NA
Q4 2020
2/25/2021
46.85-0.16-0.68NA
Q3 2020
11/10/2020
36.82-0.21-0.73NA
Q2 2020
8/11/2020
34.90-0.15-0.79NA
Q1 2020
5/12/2020
29.87-0.16-0.85NA
Q4 2019
2/27/2020
27.74-0.21NANA
Q3 2019
11/12/2019
33.49-0.27NANA
Q2 2019
8/22/2019
42.94-0.21NANA
HCAT Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/4/2022
18.27-0.03-0.12NA
Q1 2022
5/10/2022
12.95-0.06-0.24NA
Q4 2021
3/1/2022
26.56-0.19-0.76NA
Q3 2021
11/9/2021
50.51-0.18-0.72NA
Q2 2021
8/5/2021
56.890.000.00NA
Q1 2021
5/6/2021
51.47-0.06-0.24NA
Q4 2020
2/25/2021
46.85-0.16-0.64NA
Q3 2020
11/10/2020
36.82-0.21-0.84NA
Q2 2020
8/11/2020
34.90-0.15-0.60NA
Q1 2020
5/12/2020
29.87-0.16-0.64NA
Q4 2019
2/27/2020
27.74-0.21-0.84NA
Q3 2019
11/12/2019
33.49-0.27-1.08NA
Q2 2019
8/22/2019
42.94-0.21-0.84NA
Quotes delayed 20 minutes

Email EnvelopeFree HCAT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Health Catalyst (HCAT) is categorized under the Technology sector; to help you further research PE history across stocks, below are some other companies in the same sector:

HLIT PE Ratio History
HOOD PE Ratio History
HPE PE Ratio History
HPQ PE Ratio History
HSTM PE Ratio History
HUBS PE Ratio History
IAC PE Ratio History
IAS PE Ratio History
IBM PE Ratio History
IDAI PE Ratio History
On this page we presented the HCAT PE Ratio History information for Health Catalyst' stock. The average HCAT PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average HCAT PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this HCAT PE ratio history result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for HCAT had been 11.35, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on HCAT or any other given stock, valuation analysis for HCAT can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Health Catalyst PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for HCAT. Thanks for visiting, and the next time you need to research HCAT PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: MKL Price Target, Funds Holding ARHS, ETFs Holding BTI.

 

HCAT PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.